CYTK Q1 2019 Earnings — Cytokinetics, Incorporated Revenue & Financial Results | Market Cap Arena

CYTKCytokinetics, Incorporated

$8B

Q1 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$8M+60.7% YoY

Gross Profit

-$15M-178.2% margin

Operating Income

-$25M-289.7% margin

Net Income

-$29M-347.0% margin

EPS (Diluted)

$-0.54

QoQ Revenue Growth

-9.7%

Cash Flow

Operating Cash Flow

-$27M

Free Cash Flow

-$27M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$199M

Total Liabilities

$195M

Stockholders' Equity

$3M

Cash & Equivalents

$39M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$8M	$5M	+60.7%
Gross Profit	-$15M	-$17M	+10.6%
Operating Income	-$25M	-$26M	+6.2%
Net Income	-$29M	-$30M	+3.0%

Revenue Segments

Research And Development

$8M100%